The "United Kingdom Cancer Diagnostics Market, By Product (Consumables v/s Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User, By Region, Competition Forecast Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.
United Kingdom cancer diagnostics market is expected to witness robust growth in the forecast period. Cancer diagnostics is a process of identifying different proteins, biomarkers, or any other signs that can reveal the presence of a cancerous tumor in the body.
Diagnostic testing is a crucial process that can validate or eliminate the existence of an illness and monitor the stage of the disease. It helps the healthcare professionals to decide the course of action and predict and review the treatment outcomes. The diagnostic procedures which help the patients to identify cancer are laboratory tests, surgery, genetic testing, tumor biopsy, imaging, or endoscopic testing.
Factors such as the rise in consumer awareness about the benefits of early diagnosis and treatment and the increase in the number of diagnostic laboratories are primarily driving the growth of the United Kingdom cancer diagnostics market in the forecast period. Increased adoption of unhealthy eating habits and a sedentary lifestyle has escalated the occurrence of cancer across the country.
Objective of the Study:
- To analyze the historical growth in the market size of the United Kingdom Cancer diagnostics market from 2017 to 2021.
- To estimate and forecast the market size of United Kingdom Cancer diagnostics market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast the United Kingdom Cancer diagnostics market based on product, technology, application, end user, region, and company.
- To identify the dominant region or segment in the United Kingdom Cancer diagnostics market.
- To identify drivers and challenges for the United Kingdom Cancer diagnostics market.
- To examine competitive developments such as expansions, mergers acquisitions, etc., in the United Kingdom Cancer diagnostics market.
- To identify and analyze the profiles of leading players operating in the United Kingdom Cancer diagnostics market.
- To identify key sustainable strategies adopted by market players in United Kingdom Cancer diagnostics market.
Report Scope:
In this report, United Kingdom cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
United Kingdom Cancer Diagnostics Market, By Product:
- Consumables
- Instruments
United Kingdom Cancer Diagnostics Market, By Technology:
- IVD Testing
- Imaging
- Biopsy
United Kingdom Cancer Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Others
United Kingdom Cancer Diagnostics Market, By End User:
- Hospitals Clinics
- Diagnostic Laboratories
- Others
United Kingdom Cancer Diagnostics Market, By Region:
- London
- Southeast
- East Anglia
- Scotland
- Southwest
- East Midlands
- Yorkshire Humberside
- Rest of United Kingdom
Key Topics Covered:
1. Service Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Impact of COVID-19 on United Kingdom Cancer Diagnostics Market
6. United Kingdom Cancer Diagnostics Market Outlook
7. United Kingdom Cancer Diagnostics Consumables Market Outlook
8. United Kingdom Cancer Diagnostics Instruments Market Outlook
9. Market Dynamics
10. Market Trends Developments
11. Competitive Landscape
12. Strategic Recommendations
Companies Mentioned
- GE Healthcare UK Limited
- Becton, Dickinson U.K. Limited
- Roche Diagnostics UK
- Abbott Laboratories Limited
- Fujifilm Healthcare UK Limited
- Hologic (UK) Limited
- Agilent Technologies UK Limited
For more information about this report visit https://www.researchandmarkets.com/r/sy2xa1
View source version on businesswire.com: https://www.businesswire.com/news/home/20220722005135/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
